BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 17561026)

  • 1. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
    Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
    J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
    Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
    Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells (CTC) detection: clinical impact and future directions.
    Paterlini-Brechot P; Benali NL
    Cancer Lett; 2007 Aug; 253(2):180-204. PubMed ID: 17314005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
    Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; Mostert B; Martens JW; Gratama JW; Sleijfer S; Foekens JA
    Breast Cancer Res Treat; 2009 Dec; 118(3):455-68. PubMed ID: 19115104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O
    Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients.
    Breton F; Bennetau B; Lidereau R; Thomas L; Regnier G; Ehrhart JC; Tauc P; Tran PL
    Biomed Microdevices; 2011 Feb; 13(1):1-9. PubMed ID: 20814745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells.
    Molloy TJ; Bosma AJ; van't Veer LJ
    Breast Cancer Res Treat; 2008 Nov; 112(2):297-307. PubMed ID: 18213476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer.
    Vona G; Estepa L; Béroud C; Damotte D; Capron F; Nalpas B; Mineur A; Franco D; Lacour B; Pol S; Bréchot C; Paterlini-Bréchot P
    Hepatology; 2004 Mar; 39(3):792-7. PubMed ID: 14999698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological information obtainable from circulating tumor cells.
    Cristofanilli M
    Breast; 2009 Oct; 18 Suppl 3():S38-40. PubMed ID: 19914540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
    Xu T; Lu B; Tai YC; Goldkorn A
    Cancer Res; 2010 Aug; 70(16):6420-6. PubMed ID: 20663903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
    Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.